A Multi-Institution Phase II Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC).
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2015
At a glance
- Drugs Pralatrexate (Primary) ; Folic acid; Vitamin B12 analogues
- Indications Head and neck cancer
- Focus Therapeutic Use
- 09 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Apr 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 22 Apr 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.